DaVita (DVA) Form 3 DAVITA / David Paul Maughan ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Maughan David Paul

(Last) (First) (Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/15/2024

3. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Operating Officer, DKC

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	133,652(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes (i) 11,476 restricted stock units granted on March 15, 2021, which are scheduled to vest on March 15, 2025, (ii) 24,406 restricted stock united granted on March 15, 2022, which are scheduled to vest 50% each on March 15, 2025 and March 15, 2026, respectively, (iii) 34,290 restricted stock units granted on September 22, 2022, which are scheduled to vest 50% each on September 22, 2025 and September 22, 2026, respectively, (iv) 35,508 restricted stock units granted on March 15, 2023, which are scheduled to vest 50% each on March 15, 2026 and March 15, 2027, respectively and (v) 21,954 restricted stock units granted on March 15, 2024, which are scheduled to vest 50% each on March 15, 2027 and March 15, 2028, respectively. Each of the foregoing vestings is subject to continued service through each applicable vesting date.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney

	/s/ Stephanie N. Berberich, Attorney-in-Fact	09/24/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.